RPSAP39

Across TCGA pan-cancer cohorts, RPSAP39 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPSAP39’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPSAP39 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPSAP39 is over-expressed in tumor, although a few such as BLCA show the opposite, repressed pattern.

COAD, LUAD, and LIHC are the cancer types where RPSAP39 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPSAP39 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	III,IV	+0.191	.004	6	view →
LUAD	All	All	+0.131	<.001	5	view →
LIHC	Female	All	+0.037	.006	3	view →
UCEC	All	IV	+0.230	.016	2	view →
BLCA	All	All	−0.128	.023	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RPSAP39–COAD

Open the COAD breakdown →